The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation

Journal of Heart and Lung Transplantation

Volumn 29, Issue 4, 2010, Pages 424-431

  Morrell, Matthew R ^a   Despotis, George J ^a   Lublin, Douglas M ^a   Patterson, George A ^a   Trulock, Elbert P ^a   Hachem, Ramsey R ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

bronchiolitis obliterans syndrome; chronic rejection; extracorporeal; lung function; photopheresis

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; AZITHROMYCIN; CALCINEURIN INHIBITOR; CITRIC ACID; CYCLOSPORIN; FIBRINOLYTIC AGENT; GLUCONATE CALCIUM; HEPARIN; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; SODIUM CHLORIDE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; ALPHA ANTITRYPSIN DEFICIENCY; ARTICLE; BACTEREMIA; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CATHETER INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CYSTIC FIBROSIS; CYTOLYSIS; DEEP VEIN THROMBOSIS; DISEASE COURSE; DRUG EFFICACY; DRUG SUBSTITUTION; EXTRACORPOREAL PHOTOPHERESIS; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; GRAFT RECIPIENT; HUMAN; HYPOCALCEMIA; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PUVA; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BRONCHIOLITIS OBLITERANS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PHOTOPHERESIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77949567633     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.08.029     Document Type: Article

References (32)

1. Trulock E.P., Christie J.D., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report 2007. J Heart Lung Transplant 26 (2007) 782-795
2. Snell G.I., Esmore D.S., and Williams T.J. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest 109 (1996) 874-878
3. Date H., Lynch J.P., Sundaresan S., Patterson G.A., and Trulock E.P. The impact of cytolytic therapy on bronchiolitis obliterans. J Heart Lung Transplant 17 (1998) 869-875
4. Gottlieb J., Szangolies J., Koehnlein T., Golpon H., Simon A., and Welte T. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 85 (2008) 36-41
5. Shitrit D., Bendayan D., Gidon S., Saute J., Bakal I., and Kramer M.R. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 24 (2005) 1440-1443
6. Blondeau K., Mertens V., Vanaudenaerde B.A., et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 31 (2008) 707-713
7. Davis R.D., Lau C.L., Eubanks S., et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux undergoing lung transplantation. J Thorac Cardiovasc Surg 125 (2003) 533-542
8. Fisher A.J., Rutherford R.M., Bozzino J., Parry G., Dark J.H., and Corris P.A. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 5 (2005) 537-543
9. Rook A., and Cohen J. Therapeutic applications of photopheresis. Derm Clin 11 (1993) 339-347
10. Barr M.L., Meiser B.M., Eisen H.J., et al. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 339 (1998) 1744-1751
11. Costanzo-Nordin M.R., Hubbell E.A., O'Sullivan E.J., et al. Photopheresis versus corticosteroids in the therapy of heart transplant rejection: preliminary clinical report. Circulation 86 5 suppl (1992) II242-II250
12. Szczepiorkowski Z.M., Bandarenko N., Kim H.C., et al. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 22 (2007) 106-175
13. Andreu G., Achkar A., Couetil J.P., et al. Extracorporeal photochemotherapy treatment for acute lung rejection episode. J Heart Lung Transplant 14 (1995) 793-796
14. Slovis B.S., Loyd J.E., and King L.E. Photopheresis for chronic rejection of lung allografts. N Engl J Med 332 (1995) 962
15. O'Hagan A.R., Stillwell P.C., Arroliga A., and Koo A. Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation. Chest 115 (1999) 1459-1462
16. Salerno C.T., Park S.J., Kreykes N.S., et al. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg 117 (1999) 1063-1069
17. Villanueva J., Bhorade S.M., Robinson J.A., Husain A.N., and Garrity Jr. E.R. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant 5 (2000) 44-47
18. Benden C., Speich R., Hofbauer G.F., et al. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation 86 (2008) 1625-1627
19. Miller M.R., Hankinson J., Brusasco V., et al. Standardisation of spirometry. Eur Respir J 26 (2005) 319-338
20. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
21. Yoo E.K., Rook A.H., Elenitsas R., Gasparro F.P., and Vowels B.R. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphomas: relevance to mechanism of therapeutic action. J Invest Dermatol 107 (1996) 235-242
22. Suchin K.R., Cassin M., Washko R., et al. Extracorporeal photochemotherapy does not suppress T- or B-cell response to novel or recall antigens. J Am Acad Dermatol 41 (1999) 980-986
23. Lamioni A., Parisi F., Isacchi F., et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplant 79 (2005) 846-850
24. Ferguson T.A., Herndon J., Elzey B., Griffith T.S., Schoenberger S., and Green D.R. Uptake of apoptotic antigen-couples cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness. J Immunol 168 (2002) 5589-5595
25. Meloni F., Cascina A., Miserere S., Perotti C., Vitulo P., and Fietta A.M. Peripheral CD+CD25+ TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 39 (2007) 213-217
26. Tokura Y., Seo N., Yagi H., et al. Treatment of T lymphocytes with 8-methoxy-psoralen plus ultraviolet A induces transient but biologically active Th1-skewing cytokine production. J Invest Dermatol 113 (1999) 202-208
27. Vowels B.R., Cassin M., Boufal M.H., Walsha L.J., and Rook A.H. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphomas and systemic sclerosis. J Invest Dermatol 98 (1992) 686-692
28. Bladon J., and Taylor P.C. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes. Photodermatol Photoimmunol Photomed 21 (2005) 293-302
29. Cohen IR. Regulation of autoimmune disease: physiological and therapeutic. Immunol Rev 196;94:5-21.
30. Lama V.N., Murray S., Lonigro R.J., et al. Course of FEV after onset of bronchiolitis obliterans syndrome in lung transplant recipients. Am J Respir Crit Care Med 175 (2007) 1192-1198
31. Valentine V.G., Robbins R.C., Berry G.J., et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 15 (1996) 371-383
32. Heng D., Sharples L.D., McNeil K., Stewart S., Wreghitt T., and Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 17 (1998) 1255-1263